CD19-directed CAR T cells as first salvage therapy for large B-cell lymphoma: towards a rational approach
The approval of CD19-directed chimeric antigen receptor (CAR) T-cell therapies for the second-line treatment of high-risk large B-cell lymphoma (LBCL) has greatly affected salvage algorithms for this condition, and such therapies could have the potential to improve the course of relapsed or refracto...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
December 2023
|
| In: |
The lancet. Haematology
Year: 2023, Jahrgang: 10, Heft: 12, Pages: e1006-e1015 |
| ISSN: | 2352-3026 |
| DOI: | 10.1016/S2352-3026(23)00307-1 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1016/S2352-3026(23)00307-1 Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S2352302623003071 
|
| Verfasserangaben: | Peter Dreger, Paolo Corradini, John G Gribben, Bertram Glass, Mats Jerkeman, Marie Jose Kersten, Franck Morschhauser, Alberto Mussetti, Andreas Viardot, Pier Luigi Zinzani, Anna Sureda, on behalf of the European Society for Blood and Marrow Transplantation and the European Hematology Association Lymphoma Group |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1884013007 | ||
| 003 | DE-627 | ||
| 005 | 20240703155452.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240321s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/S2352-3026(23)00307-1 |2 doi | |
| 035 | |a (DE-627)1884013007 | ||
| 035 | |a (DE-599)KXP1884013007 | ||
| 035 | |a (OCoLC)1443657261 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Dreger, Peter |e VerfasserIn |0 (DE-588)1028891881 |0 (DE-627)732699894 |0 (DE-576)376320966 |4 aut | |
| 245 | 1 | 0 | |a CD19-directed CAR T cells as first salvage therapy for large B-cell lymphoma |b towards a rational approach |c Peter Dreger, Paolo Corradini, John G Gribben, Bertram Glass, Mats Jerkeman, Marie Jose Kersten, Franck Morschhauser, Alberto Mussetti, Andreas Viardot, Pier Luigi Zinzani, Anna Sureda, on behalf of the European Society for Blood and Marrow Transplantation and the European Hematology Association Lymphoma Group |
| 264 | 1 | |c December 2023 | |
| 300 | |b Illustrationen | ||
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Online verfügbar: 27. November 2023 | ||
| 500 | |a Gesehen am 21.03.2024 | ||
| 520 | |a The approval of CD19-directed chimeric antigen receptor (CAR) T-cell therapies for the second-line treatment of high-risk large B-cell lymphoma (LBCL) has greatly affected salvage algorithms for this condition, and such therapies could have the potential to improve the course of relapsed or refractory LBCL. In this Review, we provide guidance for a rational management approach to the use of commercial CD19-directed CAR T cells in the second-line treatment of LBCL, addressing crucial questions regarding eligible histologies; age, comorbidity, and tumour biology restrictions; the handling of very aggressive tumour behaviour; and holding and bridging therapies. The guidance was developed in a structured manner and, for each question, consists of a description of the clinical issue, a summary of the evidence, the rationale for a practical management approach, and recommendations. These recommendations could help to decide on the optimal management of patients with relapsed or refractory LBCL who are considered for second-line CAR T-cell treatment. | ||
| 700 | 1 | |a Corradini, Paolo |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gribben, John G. |e VerfasserIn |0 (DE-588)141998318 |0 (DE-627)704116553 |0 (DE-576)327284625 |4 aut | |
| 700 | 1 | |a Glaß, Bertram |d 1960- |e VerfasserIn |0 (DE-588)121205630 |0 (DE-627)705305538 |0 (DE-576)292585462 |4 aut | |
| 700 | 1 | |a Jerkeman, Mats |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kersten, Marie Jose |e VerfasserIn |4 aut | |
| 700 | 1 | |a Morschhauser, Franck |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mussetti, Alberto |e VerfasserIn |0 (DE-588)129573477X |0 (DE-627)1852358947 |4 aut | |
| 700 | 1 | |a Viardot, Andreas |d 1968- |e VerfasserIn |0 (DE-588)123546605 |0 (DE-627)082621357 |0 (DE-576)184707498 |4 aut | |
| 700 | 1 | |a Zinzani, Pier Luigi |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sureda, Anna |e VerfasserIn |0 (DE-588)116142993X |0 (DE-627)1024721876 |0 (DE-576)506512037 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The lancet. Haematology |d London [u.a.] : Elsevier, 2014 |g 10(2023), 12 vom: Dez., Seite e1006-e1015 |h Online-Ressource |w (DE-627)810540304 |w (DE-600)2802056-X |w (DE-576)420435689 |x 2352-3026 |7 nnas |a CD19-directed CAR T cells as first salvage therapy for large B-cell lymphoma towards a rational approach |
| 773 | 1 | 8 | |g volume:10 |g year:2023 |g number:12 |g month:12 |g pages:e1006-e1015 |g extent:10 |a CD19-directed CAR T cells as first salvage therapy for large B-cell lymphoma towards a rational approach |
| 856 | 4 | 0 | |u https://doi.org/10.1016/S2352-3026(23)00307-1 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S2352302623003071 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20240321 | ||
| 993 | |a Article | ||
| 994 | |a 2023 | ||
| 998 | |g 1028891881 |a Dreger, Peter |m 1028891881:Dreger, Peter |d 910000 |d 910100 |e 910000PD1028891881 |e 910100PD1028891881 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1884013007 |e 4502842737 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"title":[{"subtitle":"towards a rational approach","title":"CD19-directed CAR T cells as first salvage therapy for large B-cell lymphoma","title_sort":"CD19-directed CAR T cells as first salvage therapy for large B-cell lymphoma"}],"person":[{"family":"Dreger","display":"Dreger, Peter","role":"aut","given":"Peter"},{"role":"aut","given":"Paolo","display":"Corradini, Paolo","family":"Corradini"},{"family":"Gribben","display":"Gribben, John G.","role":"aut","given":"John G."},{"family":"Glaß","display":"Glaß, Bertram","given":"Bertram","role":"aut"},{"given":"Mats","role":"aut","display":"Jerkeman, Mats","family":"Jerkeman"},{"family":"Kersten","role":"aut","given":"Marie Jose","display":"Kersten, Marie Jose"},{"given":"Franck","role":"aut","display":"Morschhauser, Franck","family":"Morschhauser"},{"given":"Alberto","role":"aut","display":"Mussetti, Alberto","family":"Mussetti"},{"display":"Viardot, Andreas","role":"aut","given":"Andreas","family":"Viardot"},{"display":"Zinzani, Pier Luigi","given":"Pier Luigi","role":"aut","family":"Zinzani"},{"family":"Sureda","role":"aut","given":"Anna","display":"Sureda, Anna"}],"name":{"displayForm":["Peter Dreger, Paolo Corradini, John G Gribben, Bertram Glass, Mats Jerkeman, Marie Jose Kersten, Franck Morschhauser, Alberto Mussetti, Andreas Viardot, Pier Luigi Zinzani, Anna Sureda, on behalf of the European Society for Blood and Marrow Transplantation and the European Hematology Association Lymphoma Group"]},"note":["Online verfügbar: 27. November 2023","Gesehen am 21.03.2024"],"relHost":[{"disp":"CD19-directed CAR T cells as first salvage therapy for large B-cell lymphoma towards a rational approachThe lancet. Haematology","physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2802056-X"],"issn":["2352-3026"],"eki":["810540304"]},"note":["Gesehen am 27.11.14"],"type":{"media":"Online-Ressource","bibl":"periodical"},"titleAlt":[{"title":"The lancet <London> / Haematology"}],"recId":"810540304","origin":[{"dateIssuedKey":"2014","publisher":"Elsevier","dateIssuedDisp":"2014-","publisherPlace":"London [u.a.]"}],"pubHistory":["1.2014 -"],"title":[{"partname":"Haematology","title":"The lancet","title_sort":"lancet"}],"part":{"volume":"10","text":"10(2023), 12 vom: Dez., Seite e1006-e1015","year":"2023","issue":"12","pages":"e1006-e1015","extent":"10"},"language":["eng"]}],"physDesc":[{"noteIll":"Illustrationen","extent":"10 S."}],"id":{"eki":["1884013007"],"doi":["10.1016/S2352-3026(23)00307-1"]},"origin":[{"dateIssuedDisp":"December 2023","dateIssuedKey":"2023"}],"recId":"1884013007","type":{"bibl":"article-journal","media":"Online-Ressource"}} | ||
| SRT | |a DREGERPETECD19DIRECT2023 | ||